Adocia SA ADOC.PA Stock
Adocia SA Price Chart
Adocia SA ADOC.PA Financial and Trading Overview
| Adocia SA stock price | 8.87 EUR |
| Previous Close | 3.96 EUR |
| Open | 4 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 3.87 - 4.05 EUR |
| 52 Week Range | 2.75 - 5.6 EUR |
| Volume | 61.71K EUR |
| Avg. Volume | 50.36K EUR |
| Market Cap | 35.35M EUR |
| Beta (5Y Monthly) | 0.880459 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.36 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.3 EUR |
ADOC.PA Valuation Measures
| Enterprise Value | 50.23M EUR |
| Trailing P/E | N/A |
| Forward P/E | -2.9774435 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.0364132 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.893 |
| Enterprise Value/EBITDA | -4.071 |
Trading Information
Adocia SA Stock Price History
| Beta (5Y Monthly) | 0.880459 |
| 52-Week Change | -1.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.6 EUR |
| 52 Week Low | 2.75 EUR |
| 50-Day Moving Average | 3.36 EUR |
| 200-Day Moving Average | 3.57 EUR |
ADOC.PA Share Statistics
| Avg. Volume (3 month) | 50.36K EUR |
| Avg. Daily Volume (10-Days) | 6.13K EUR |
| Shares Outstanding | 8.93M |
| Float | 6.37M |
| Short Ratio | N/A |
| % Held by Insiders | 21.14% |
| % Held by Institutions | 15.58% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -39.75% |
| Operating Margin (ttm) | -74.28% |
| Gross Margin | -70.042% |
| EBITDA Margin | -71.067% |
Management Effectiveness
| Return on Assets (ttm) | -26.57% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 17.36M EUR |
| Revenue Per Share (ttm) | 2.16 EUR |
| Quarterly Revenue Growth (yoy) | 96.89% |
| Gross Profit (ttm) | N/A |
| EBITDA | -12338000 EUR |
| Net Income Avi to Common (ttm) | -6901000 EUR |
| Diluted EPS (ttm) | -0.9 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.42M EUR |
| Total Cash Per Share (mrq) | 2 EUR |
| Total Debt (mrq) | 33.21M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.047 |
| Book Value Per Share (mrq) | -1.491 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14995000 EUR |
| Levered Free Cash Flow (ttm) | -2475875 EUR |
Profile of Adocia SA
| Country | France |
| State | N/A |
| City | Lyon |
| Address | 115 Avenue Lacassagne |
| ZIP | 69003 |
| Phone | 33 4 72 61 06 10 |
| Website | https://www.adocia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 96 |
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic proteins. The company's clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations based on rapid insulin lispro; BioChaperone Combo, a combination of acting insulin glargine and rapid-acting insulin lispro; BioChaperone LisPram, a combination of prandial insulin with pramlintide; and BioChaperone Glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as M1Pram, a metabolite of insulin glargine and pramlintide. Its preclinical pipeline includes products for the treatment of diabetes and obesity comprising AdoShell Islets, an implant containing islets of Langerhans; AdOral Sema, an oral delivery of semaglutide; and BioChaperone GluExe, a combination of glucagon and exenatide. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was incorporated in 2005 and is headquartered in Lyon, France.
Q&A For Adocia SA Stock
What is a current ADOC.PA stock price?
Adocia SA ADOC.PA stock price today per share is 8.87 EUR.
How to purchase Adocia SA stock?
You can buy ADOC.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adocia SA?
The stock symbol or ticker of Adocia SA is ADOC.PA.
Which industry does the Adocia SA company belong to?
The Adocia SA industry is Biotechnology.
How many shares does Adocia SA have in circulation?
The max supply of Adocia SA shares is 14.29M.
What is Adocia SA Price to Earnings Ratio (PE Ratio)?
Adocia SA PE Ratio is now.
What was Adocia SA earnings per share over the trailing 12 months (TTM)?
Adocia SA EPS is -2.36 EUR over the trailing 12 months.
Which sector does the Adocia SA company belong to?
The Adocia SA sector is Healthcare.
Adocia SA ADOC.PA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| CAC Mid & Small MS190 | 14267.59 EUR 15596.4 USD |
-0.38
|
— — | — — | — — | — - | — — |
| CAC Small CS90 | 11739.13 EUR 12832.46 USD |
-0.74
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}